A Multiple-Dose Pharmacokinetic Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Subjects With Elevated Fasting Triglyceride Levels.
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2014
At a glance
- Drugs Diazoxide (Primary)
- Indications Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors Essentialis
- 04 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 04 Nov 2010 Additional lead trial investigator (Alan K Copa) identified as reported by ClinicalTrials.gov.
- 04 Nov 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.